Top Markets
#1 Orochi Network Orochi Network +75.87%
#2 Bitway Bitway +26.98%
#3 Audiera Audiera +26.10%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.60%
#5 Pharos Pharos +15.97%
#6 SOON SOON +15.22%
#7 DeXe DeXe +14.77%
#8 Taiko Taiko +13.85%
#9 Manadia Manadia +13.47%
#10 ROLL ROLL +13.27%
Coin of the day
Orochi Network Orochi Network
설정
언어
한국어
통화
USD
테마
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
주식 순위 #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
주가
$50.95
시가총액
$226.41B
변동 (1일)
2.58%
변동 (1년)
-26.16%
국가
DK
거래 Novo Nordisk A/S (NVO)

카테고리

Healthcare
Novo Nordisk A/S (NVO)의 P/S 비율
July 2026 기준 P/S 비율 TTM: 4.33
Novo Nordisk A/S의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 4.33입니다. 2024년 말 기준 P/S 비율은 9.57였습니다.
Novo Nordisk A/S의 P/S 비율 기록 (2000 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 4.33 -7.42%
2025 4.68 -51.16%
2024 9.57 -28.95%
2023 13.47 12.21%
2022 12.01 0.14%
2021 11.99 52.88%
2020 7.84 4.26%
2019 7.52 14.27%
2018 6.58 -10.96%
2017 7.39 28.28%
2016 5.76 -39.48%
2015 9.53 23.95%
2014 7.69 20.58%
2013 6.37 -2.85%
2012 6.56 16.63%
2011 5.62 -6.38%
2010 6.01 54.26%
2009 3.89 6.22%
2008 3.67 -25.10%
2007 4.90 23.93%
2006 3.95 14.37%
2005 3.45 -0.13%
2004 3.46 11.99%
2003 3.09 9.60%
2002 2.82 -43.18%
2001 4.96 6.86%
2000 4.64 0.00%
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.86 127.68%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
4.53 4.57%
US
UCB SA UCB SA
UCB SA
UCB.BR
5.72 31.96%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
16.03 269.94%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
8.76 102.17%
US